Li; Shaoling

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Shaoling.The latest application filed is for "solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2- -oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl}methanol, a shp2 inhibitor".

Company Profile

7.7.28

Li; Shaoling - Sunnyvale CA
LI; Shaoling - Redwood City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 11,452,723 - Li , et al. September 27, 2	2022-09-27
Solid Forms Of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2- -oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl}methanol, A Shp2 Inhibitor App 20220298159 - LI; Shaoling ; et al.	2022-09-22
Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2- -oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor Grant 11,220,501 - Li , et al. January 11, 2	2022-01-11
Solid Forms Of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2- -oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl}methanol, An Shp2 Inhibitor App 20210253574 - LI; Shaoling ; et al.	2021-08-19
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20210161884 - Li; Shaoling ; et al.	2021-06-03
Transdermal Administration Of Fentanyl And Analogs Thereof App 20210113541 - VENKATRAMAN; Subramanian S. ; et al.	2021-04-22
Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 10,946,009 - Li , et al. March 16, 2	2021-03-16
Transdermal Administration Of Fentanyl And Analogs Thereof App 20200289488 - VENKATRAMAN; Subramanian ; et al.	2020-09-17
Transdermal Administration Of Fentanyl And Analogs Thereof App 20200054619 - VENKATRAMAN; Subramanian ; et al.	2020-02-20
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20190321350 - Li; Shaoling ; et al.	2019-10-24
Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 10,369,142 - Li , et al.	2019-08-06
Transdermal Administration Of Fentanyl And Analogs Thereof App 20190167655 - VENKATRAMAN; Subramanian ; et al.	2019-06-06
Transdermal Administration Of Fentanyl And Analogs Thereof App 20180098979 - VENKATRAMAN; SUBRAMANIAN S. ; et al.	2018-04-12
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20180050028 - Li; Shaoling ; et al.	2018-02-22
Transdermal Administration Of Fentanyl And Analogs Thereof App 20160331740 - VENKATRAMAN; SUBRAMANIAN S. ; et al.	2016-11-17
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20160287573 - Li; Shaoling ; et al.	2016-10-06
Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles Grant 9,066,870 - Hu , et al. June 30, 2	2015-06-30
Transdermal Administration Of Fentanyl And Analogs Thereof App 20140271799 - VENKATRAMAN; SUBRAMANIAN S. ; et al.	2014-09-18
Transdermal Administration Of Fentanyl And Analogs Thereof App 20140030316 - Venkatraman; Subramanian S. ; et al.	2014-01-30
Methods For Drug Delivery Comprising Unfolding And Folding Proteins And Peptide Nanoparticles App 20110059181 - Hu; Yiqiao ; et al.	2011-03-10
Sustained release formulations containing acetaminophen and tramadol App 20090162431 - Zhang; Shuyi ; et al.	2009-06-25
Transdermal Administration Of Fentanyl And Analogs Thereof App 20090004257 - Venkatraman; Subramanian S. ; et al.	2009-01-01
Expandable osmotic composition and coating suspension Grant 7,338,663 - Li , et al. March 4, 2	2008-03-04
Novel Drug Compositions And Dosage Forms Of Topiramate App 20070243254 - Edgren; David ; et al.	2007-10-18
Transdermal administration of fentanyl and analogs thereof App 20050208117 - Venkatraman, Subramanian S. ; et al.	2005-09-22
Novel drug compositions and dosage forms of topiramate App 20050175697 - Edgren, David ; et al.	2005-08-11
Novel drug compositions and dosage forms App 20050175690 - Edgren, David ; et al.	2005-08-11
Controlled release of topiramate in liquid dosage forms App 20050129765 - Li, Shaoling ; et al.	2005-06-16
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation App 20050058707 - Reyes, Iran ; et al.	2005-03-17
Transdermal administration of fentanyl and analogs thereof App 20040213832 - Venkatraman, Subramanian S. ; et al.	2004-10-28
Formulations and dosage forms for controlled delivery of topiramate App 20040115262 - Jao, Frank ; et al.	2004-06-17
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery App 20040091529 - Edgren, David ; et al.	2004-05-13
Expandable osmotic composition and coating suspension App 20040058002 - Li, Shaoling ; et al.	2004-03-25
Transdermal administration of fentanyl and analogs thereof App 20030026829 - Venkatraman, Subramanian S. ; et al.	2003-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.